one8zero8 LLC Acquires Shares of 186,020 Calumet, Inc. $CLMT
one8zero8 LLC recently acquired 186,020 shares of Calumet, Inc. (NASDAQ:CLMT) worth approximately $6.7 million, making it their 17th-largest holding. This acquisition comes as Calumet reported Q2 revenue of $1.45 billion, a 40.8% year-over-year increase, but missed earnings expectations with a loss of $1.09 per share. Analyst sentiment for Calumet remains mixed, with a "Hold" consensus and an average price target of $42.75.
Calumet stock hits 52-week high at 49.27 USD By Investing.com
Calumet Specialty Products Partners (CLMT) stock recently reached a 52-week high of $49.17 USD, pushing its market capitalization to $4.31 billion. This surge reflects a 1-year total return of 265.46% and a year-to-date gain of 143%, although InvestingPro analysis suggests the stock is currently overvalued and was not profitable in the past year, with analysts predicting profitability this year. The company reported mixed Q2 2026 results, surpassing revenue estimates with $1.44 billion but missing EPS projections with a loss of $1.09 per share, yet generated $175 million in adjusted EBITDA.
Is Calumet Inc (CLMT) Overvalued After 5.1% Rally? GF Value Says
Calumet Inc (CLMT) saw a 5.1% rally, but GuruFocus's GF Value suggests the stock is significantly overvalued at $50.81 compared to its intrinsic value of $18.23, indicating a 178.7% overvaluation. The company's GF Score of 54/100 points to mixed performance, with concerns arising from its unprofitability, negative cash flow, and substantial insider selling without any buying activity. Investors are advised to exercise caution due to these red flags.
Calumet stock hits 52-week high at 49.27 USD By Investing.com
Calumet Specialty Products Partners (CLMT) stock has reached a new 52-week high of $49.17 USD, pushing its market capitalization to $4.31 billion and demonstrating a significant 1-year return of 265.46%. While InvestingPro analysis indicates the stock is currently overvalued and the company was not profitable last year, analysts predict profitability for the current year. The company recently reported mixed Q2 2026 results with revenue beating estimates but adjusted EPS falling short, leading TD Cowen to raise its price target to $40 while maintaining a Hold rating.
Calumet stock hits 52-week high at 49.27 USD By Investing.com
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $49.17 USD, pushing its market capitalization to $4.31 billion, driven by a 265.46% 1-year total return and a 143% year-to-date gain. Despite strong investor confidence and recent revenue surpassing estimates, the company reported an adjusted EPS loss of $1.09 for Q2 2026, missing anticipated profits. Analysts predict profitability for the current year, and TD Cowen raised its price target to $40 while maintaining a Hold rating.
Is Calumet’s Q2 Revenue Growth but Deeper H1 Loss Altering The Investment Case For Calumet (CLMT)?
Calumet (CLMT) reported increased Q2 2026 revenue and a narrower quarterly net loss, but its net loss for the first half of 2026 significantly widened despite higher sales, indicating ongoing profitability challenges. The investment case hinges on the company's shift towards higher-value renewables and specialty products outweighing legacy operations and debt, with debt management remaining a critical factor. While some analysts are optimistic about future revenue and earnings, the widening year-to-date losses and substantial debt present risks to investors.
Is Calumet’s Q2 Revenue Growth but Deeper H1 Loss Altering The Investment Case For Calumet (CLMT)?
Calumet, Inc. reported increased sales in Q2 2026 but a wider net loss for H1 2026, driven by ongoing profitability pressures despite revenue growth. The company's investment narrative continues to hinge on its shift to renewables and specialty products offsetting legacy operations and leverage, with debt management being a critical factor. While Q2 saw narrowed losses, the larger first-half loss highlights persistent balance sheet risks and cash generation concerns.
Russell Investments Group Ltd. Buys 30,990 Shares of Calumet, Inc. $CLMT
Russell Investments Group Ltd. increased its stake in Calumet, Inc. by 239.4% in the second quarter, purchasing an additional 30,990 shares to bring its total holding to 43,935 shares valued at $1.58 million. Despite this significant institutional investment, analyst sentiment for Calumet is mixed, with a consensus "Hold" rating and an average price target of $41.50. The company recently reported quarterly revenue of $1.45 billion, a 40.8% year-over-year increase, but missed earnings expectations with a loss of $1.09 per share.
Two Seas Capital (CLMT) discloses 7.5% Calumet stake via Two Seas Global Fund
Two Seas Capital LP, along with its affiliates, has reported a beneficial ownership of 7.5% in Calumet, Inc. (CLMT) through its Schedule 13G/A filing. This stake, totaling 6,619,708 shares of common stock, is held by Two Seas Global (Master) Fund LP. The filing indicates that Two Seas Capital and its reporting persons possess sole voting and dispositive power over these shares.
Wasserstein group (CLMT) discloses 4.6% Calumet Inc. ownership in Schedule 13G/A
Wasserstein Management L.P. and its affiliated entities have reported a beneficial ownership of 4.6% in Calumet Inc. (CLMT) common stock, as detailed in an amended Schedule 13G filing on June 30, 2026. This stake amounts to 3,964,893 shares out of 87,147,147 total shares outstanding. The ownership is primarily held through Wasserstein Master, LP and separately managed accounts, with shared voting and dispositive power among affiliated general partners and control persons, including Rajay Bagaria and Joseph Dutton.
Bank of America Corp DE Purchases 454,985 Shares of Calumet, Inc. $CLMT
Bank of America Corp DE significantly increased its stake in Calumet, Inc. (NASDAQ:CLMT) by 65.1% in the first quarter, adding 454,985 shares to reach a total holding of 1.15 million shares valued at $41.4 million. Despite a 40.8% year-over-year revenue increase to $1.45 billion, Calumet reported an adjusted loss of $1.09 per share, missing analyst estimates. Analysts currently maintain a "Hold" rating on the stock with an average price target of $41.50, which is below the current share price.
Calumet, Inc. (NASDAQ:CLMT) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Calumet, Inc. (NASDAQ:CLMT) shareholders saw an 11% stock price increase after the company reported second-quarter results with revenues 29% better than expected, despite statutory losses ballooning. Analysts have since lifted their revenue estimates for 2026 to US$4.98 billion and favorably reduced loss per share forecasts to US$2.89. The consensus price target has risen by 5.7% to US$41.00, reflecting increased optimism and expectations for Calumet to grow faster than its industry.
Calumet (CLMT) Could Be 22% Overvalued On Strait Of Hormuz Oil Jitters
Calumet (CLMT) is being re-evaluated by investors following geopolitical risks in the Strait of Hormuz, which have driven Brent crude prices higher. While the stock has shown significant recent momentum and trades above the average analyst price target, one narrative suggests it is 21.6% overvalued at $47.19 with a fair value of $38.80, primarily due to reliance on renewable fuel regulations and a substantial debt load. Conversely, a DCF model indicates potential undervaluation at $72.27, suggesting mixed signals on its true value.
Calumet, Atlas Energy Solutions, HighPeak Energy, Borr Drilling, and ProFrac Shares Are Soaring, What You Need To Know
Shares of several energy-related companies, including Calumet, Atlas Energy Solutions, HighPeak Energy, Borr Drilling, and ProFrac, jumped following a rebound in Brent crude prices. This surge is attributed to geopolitical tensions in the Strait of Hormuz, with an incident involving a UAE vessel and potential Iranian legislation impacting shipping traffic. The market is pricing in a geopolitical risk premium, leading to higher expected cash flows for E&P companies, despite uncertainty about the long-term resolution of the situation.
CLMT Maintained by TD Cowen -- Price Target Raised to $40.00
TD Cowen has maintained a "Hold" rating for Calumet (CLMT) but raised its price target from $34.00 to $40.00. Despite this, GuruFocus assesses CLMT as significantly overvalued with a GF Value™ of $18.19 against its current price of $47.12. Insider selling totaling $20.6 million further suggests caution for investors, despite moderate GF Score™ indicating some profitability and growth strengths.
TD Cowen raises Calumet stock price target on strong specialty results
TD Cowen has increased its price target for Calumet Specialty Products Partners (NASDAQ:CLMT) to $40 from $34, maintaining a Hold rating. This adjustment follows strong second-quarter specialty results and an expected robust second half of 2026, though base oil margins are anticipated to normalize. The firm noted Calumet's significant debt paydown and improved margin forecasts, despite the stock appearing overvalued according to InvestingPro analysis.
Calumet, Inc. (NASDAQ:CLMT) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Calumet, Inc. reported better-than-expected second-quarter revenues of US$1.4 billion, though statutory losses increased significantly to US$1.09 per share. Following these results, analysts have raised their revenue forecasts for 2026 to US$4.98 billion and reduced their loss per share estimates to US$2.89. The consensus price target for Calumet also increased by 5.7% to US$41.00, reflecting increased optimism about the company's future growth prospects compared to the broader industry.
Calumet, Inc. (NASDAQ:CLMT) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Calumet, Inc. (NASDAQ:CLMT) reported strong second-quarter revenues, exceeding analyst expectations by 29%, despite increased statutory losses. Following these results, analysts have raised their revenue forecasts for 2026 and significantly reduced their loss per share estimates, indicating increased optimism for the company's future growth. The consensus price target for Calumet also saw a 5.7% increase, reflecting confidence in improved intrinsic value and an expected acceleration in revenue growth well above the industry average.
Montana Renewables begins next phase of MaxSAF expansion
Montana Renewables, a subsidiary of Calumet, has initiated the next phase of its MaxSAF expansion project. The article, authored by Erin Krueger, was published on August 10, 2026. This development marks a significant step for the company in expanding its sustainable aviation fuel capabilities.
Calumet releases transcript of Q2 2026 earnings call
Calumet's Q2 2026 earnings call featured CEO Todd Borgmann and other key executives. The company reported Adjusted EBITDA with Tax Attributes of $175 million, with restricted group leverage falling below 4x and a target of below 3x for the next quarter. Debt actions included calling $100 million of 2028 mirror notes and a $115 million repurchase to terminate a truck rack sale-leaseback. Montana Renewables posted $17 million in Adjusted EBITDA despite downtime, and MaxSAF expansion plans were updated to a lower-cost reconfiguration aiming for 120-150 million gallons by spring 2027 and 200 million by 2028.
FY2027 Earnings Estimate for Calumet Issued By HC Wainwright
HC Wainwright has lowered its FY2027 EPS estimate for Calumet to $0.59 from $0.69, while the current full-year consensus remains a loss of $0.13 per share. This follows Calumet reporting a quarterly EPS of ($1.09), missing the consensus estimate of $0.07, despite revenue increasing by 40.8% year over year to $1.45 billion. Analyst sentiment for Calumet is mixed, with an average "Hold" rating and a price target of $37.75, compared to its opening price of $45.47.
Calumet (NASDAQ:CLMT) Sets New 12-Month High - Here's What Happened
Calumet (NASDAQ:CLMT) shares recently surged to a new 52-week high of $45.55, closing at $45.47, a 15.2% increase from its previous close. This rise occurred despite analysts holding a consensus "Hold" rating with an average price target of $37.75, and the company reporting an adjusted loss of $1.09 per share in its latest quarter, missing profit estimates. The company's revenue, however, increased by 40.8% year over year to $1.45 billion.
Calumet stock reaches 52-week high at $45.20
Calumet Inc. (CLMT) stock hit a new 52-week high of $45.20, currently trading at $45.32, reflecting a 237.98% increase over the past year. Despite its overvalued status and unprofitability in the last twelve months, analysts predict profitability for the company this year. Recent Q2 2026 results showed strong revenue of $1.44 billion but missed EPS estimates with a loss of $1.09.
CLMT Stock Jumps As Revenue Beat Fuels Deleveraging Story
Calumet Inc. (CLMT) stock rose over 10% after reporting strong Q2 2026 revenue of $1.45 billion, significantly beating estimates, and narrowing its loss. The company's focus on specialty products, $115 million in debt reduction, and the expansion of its Montana Renewables MaxSAF 150 project are driving investor optimism, despite remaining profitability challenges and high leverage. Goldman Sachs raised its price target to $40 while maintaining a Neutral rating, indicating cautious acknowledgment of progress.
Calumet Up Nearly 12%, on Track for Highest Close Since November 2007 -- Data Talk
Calumet, Inc. (CLMT) stock is up nearly 12%, trading at $44.22, and is on track for its highest close since November 2007. The company's stock has shown significant year-to-date growth of 122.52% and is up 233.2% from 52 weeks ago, setting a potential new 52-week closing high.
Calumet, Inc. 2026: Revenue $1.45B, EPS ($1.09) — 10-Q Summary
Calumet, Inc. (CLMT) reported its Q2 2026 results, showing revenue of $1.45 billion, a significant increase from the previous year, and a narrower net loss of ($95.9 million) with diluted EPS of ($1.09). The company experienced revenue growth and margin recovery driven by specialty and renewables sales, a shift towards higher-value SAF after the MaxSAF®150 restart, and strong performance in its Performance Brands. Operational highlights include the completion of the MaxSAF®150 expansion and increased specialty products production despite planned downtime in Montana renewables.
Is Calumet Inc (CLMT) Recovering? Q2 Earnings Show EPS at -1.09
Calumet Inc (CLMT) reported a net loss of $95.9 million and an EPS of $(1.09) for Q2 2026, significantly missing analyst estimates of $(0.34) despite exceeding revenue expectations with $1.445 billion. The company faced substantial headwinds due to an unrealized non-cash loss from Renewable Identification Numbers (RINs) but showed improved operational execution, with Adjusted EBITDA reaching $175.2 million. GuruFocus rates CLMT as 161.9% overvalued with a low financial strength score, and recent insider selling raises further caution for investors.
Calumet Q2 2026 Earnings: Specialty Strength Lifts Adjusted EBITDA
Calumet (NASDAQ: CLMT) reported strong Q2 2026 earnings, with sales up 40.8% year-over-year to $1.445 billion, driven primarily by its Specialty Products and Solutions segment. Despite significant noncash RIN-related expenses that led to a net loss, adjusted EBITDA saw a substantial increase to $159.3 million. The company's performance highlights the importance of sustained specialty margins, improved cash conversion, and continued debt reduction to manage its significant leverage and RIN liabilities.
Earnings Flash (CLMT) Calumet, Inc. Reports Q2 Revenue $1.45B, vs. FactSet Est of $1.12B
Calumet, Inc. (CLMT) reported its Q2 revenue at $1.45 billion, significantly surpassing FactSet's estimate of $1.12 billion. This financial update indicates a stronger than anticipated sales performance for the company during the second quarter of 2026. The news was released by MT Newswires on August 7, 2026, at 07:18 am EDT.
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Rating of "Hold" from Brokerages
Calumet, Inc. (NASDAQ:CLMT) has received a consensus "Hold" rating from brokerages, with an average 12-month price target of $37.75. The company recently missed earnings expectations, reporting a loss of $1.09 per share against an anticipated profit of $0.07, despite a 40.8% year-over-year increase in revenue. Insider sales by major shareholder Group Heritage and a director have also been noted, contributing to a 5.7% drop in share price.
Calumet (NASDAQ:CLMT) Releases Earnings Results, Misses Expectations By $1.16 EPS
Calumet (NASDAQ:CLMT) announced its quarterly earnings, reporting a significant miss with a loss of $1.09 per share, largely below the consensus estimate of $0.07. Despite the EPS miss, the company's revenue increased by 40.8% year-over-year to $1.45 billion, surpassing analysts' expectations. Following the release, Calumet's shares dropped by 5.7%, while analysts maintain a "Hold" rating with a target price of $37.75.
Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026
Calumet (NASDAQ:CLMT) reported strong Q2 CY2026 results, surpassing Wall Street's revenue and adjusted EBITDA expectations with sales up 40.8% year-on-year to $1.45 billion. Despite a GAAP EPS miss, the company's adjusted EBITDA significantly exceeded estimates, and its free cash flow turned positive. The report highlights Calumet's decent long-term revenue growth and improved operating efficiency, suggesting a potential inflection point for the specialty products refiner.
Calumet, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CLMT) 2026-08-07
This article provides access to the earnings call presentation slides published by Calumet, Inc. (NASDAQ:CLMT) for its Q2 2026 results. The company reported Q2 EPS of $0.68, beating estimates by $0.52, and revenue of $1.45 billion, surpassing expectations by $324.37 million, representing a 40.77% year-over-year increase.
Press Release: Calumet Reports Second Quarter 2026 Results
This press release from Calumet reports their financial results for the second quarter of 2026. It will detail key financial metrics and operational highlights for the period. Investors and stakeholders will find information regarding the company's performance and outlook.
Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026
Calumet (NASDAQ:CLMT) reported strong Q2 CY2026 results, with revenue up 40.8% year-on-year to $1.45 billion, significantly beating Wall Street expectations. The specialty products refiner also exceeded adjusted EBITDA consensus estimates, posting $175.2 million. Despite a GAAP EPS miss, the company showed improved operating margins and a positive free cash flow of $99.35 million, marking a potential inflection point.
Calumet Q2 Loss Narrows, Revenue Rises
Calumet (CLMT) reported that its Q2 loss narrowed to $1.09 per basic share. This financial improvement was accompanied by an increase in revenue, though specific figures for the revenue rise were not detailed in the provided snippet. The article requires a premium subscription for full access to the MT Newswires report.
Calumet (CLMT) Q2 Earnings Report Preview: What To Look For
Calumet (CLMT) is set to report its Q2 earnings tomorrow morning, with analysts expecting a 6.6% year-on-year revenue growth. The company previously beat revenue expectations but missed EBITDA estimates in the last quarter. Investors are monitoring Calumet's performance relative to its infrastructure peers and its current stock price compared to the average analyst target.
Janus Henderson Group PLC Buys 186,648 Shares of Calumet, Inc. $CLMT
Janus Henderson Group PLC significantly increased its stake in Calumet, Inc. (NASDAQ:CLMT) by 596.3% in the first quarter, purchasing 186,648 additional shares to own a total of 217,948 shares valued at $7.8 million. This comes despite Calumet reporting a substantial quarterly earnings miss, with a loss of $3.64 per share, significantly below analyst expectations, though revenue increased by 3.6% year-over-year. Analysts currently hold a consensus "Hold" rating for Calumet with an average price target of $37.75, which is below the stock's recent opening price of $40.26, and insiders have also been selling shares.
Calumet, Inc. (CLMT) Stock Price, News, Quote & History
This article provides a detailed overview of Calumet, Inc. (CLMT) stock, including its current price, historical performance, and key financial data. It highlights the company's business segments in specialty chemicals and renewable fuels, along with analyst insights and performance comparisons against benchmarks. The information is presented in a typical financial news format, offering various metrics for potential investors.
Calumet, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Calumet, Inc. is projected to report a loss of 13 cents per share, according to this earnings preview. The article from Reuters indicates upcoming financial news for the company. Users can access the full article through TradingView's news platform.
Renaissance Technologies LLC Makes New Investment in Calumet, Inc. $CLMT
Renaissance Technologies LLC has initiated a new investment in Calumet, Inc. (NASDAQ:CLMT), purchasing 391,800 shares valued at approximately $14.1 million. This move comes as Calumet faces a "Hold" rating from analysts and recently reported an EPS loss significantly below expectations, despite a 3.6% increase in revenue. Insider selling by major shareholders and a director has also been noted, reflecting a mixed sentiment around the oil and gas company.
CLMT|Calumet Inc|Price:44.190|Chg%:+0.440
Calumet Inc. (CLMT) is currently trading at $44.190, up 1.01%, with a market cap of $3.85 billion. Analysts have rated it a "Buy" with a target price of $39.50, despite some weak fundamentals and technicals. The company specializes in manufacturing and marketing specialty branded products and renewable fuels through its diverse segments.
Healthcare of Ontario Pension Plan Trust Fund Grows Holdings in Calumet, Inc. $CLMT
The Healthcare of Ontario Pension Plan Trust Fund significantly increased its stake in Calumet, Inc. (NASDAQ:CLMT) by 107% in the first quarter, now holding 97,741 shares valued at $3.5 million. Despite this increased institutional interest, analysts maintain a "Hold" rating for CLMT with an average price target of $37.75, even as the stock trades near its 12-month high of $45.20 and recently missed earnings estimates. Insider selling by a major shareholder and a director also occurred, indicating mixed signals for the company's stock performance.
First Trust Advisors LP Acquires 92,368 Shares of Calumet, Inc. $CLMT
First Trust Advisors LP has increased its stake in Calumet, Inc. by 36.2%, acquiring an additional 92,368 shares, bringing their total holdings to 347,486 shares valued at $12.475 million. Other institutional investors like Legal & General Group Plc, New York State Common Retirement Fund, and Invesco Ltd. also adjusted their positions in Calumet, which currently has a "Hold" rating from analysts with a consensus price target of $37.75. Insider transactions included share sales by Director Daniel J. Sajkowski and major shareholder Group Heritage.
Calumet (CLMT) Expected to Post Earnings on Friday
Calumet (CLMT) is scheduled to release its Q2 2026 earnings before the market open on Friday, August 7th. Analysts anticipate earnings of $0.0674 per share and revenue of $1.1125 billion, following a previous quarter where the company missed EPS estimates but saw a 3.6% revenue increase. Despite Calumet shares climbing 3.2% near a 12-month high, analyst sentiment remains cautious with an average "Hold" rating and a consensus price target below its current opening price.
What is HC Wainwright's Forecast for Calumet Q1 Earnings?
HC Wainwright forecasts Calumet (NASDAQ:CLMT) to earn $0.20 per share in Q1 2027, with full-year consensus estimates at a loss of $0.13 per share. Despite opening near its 52-week high, Calumet currently holds an average "Hold" rating from analysts and an average price target of $36.75. The company recently missed Q1 earnings expectations significantly, reporting a $3.64 per-share loss against a projected $0.33 loss, though revenue grew 3.6% year-over-year.
Understanding the Setup: (CLMT) and Scalable Risk
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT) using AI models, highlighting a weak near-term sentiment but strong mid and long-term outlook. It identifies an exceptional 35.4:1 risk-reward short setup and provides three distinct trading strategies: a Long Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Short Strategy, along with multi-timeframe signal analysis.
Q2 Earnings Forecast for Calumet Issued By HC Wainwright
HC Wainwright has issued a Q2 2027 earnings per share forecast of $0.19 for Calumet (NASDAQ:CLMT), maintaining a "Buy" rating and a $60.00 price target. This target significantly exceeds the broader analyst consensus of $36.75. Despite a recent quarterly loss of $3.64 per share, the company's stock has risen from its one-year low, and institutional investors hold a substantial stake.
Rangeley Capital LLC Has $1.90 Million Stock Holdings in Calumet, Inc. $CLMT
Rangeley Capital LLC significantly reduced its stake in Calumet, Inc. (NASDAQ:CLMT) by 79.6% in the first quarter, holding 53,000 shares valued at approximately $1.9 million. Despite this, other institutional investors increased their positions, with overall institutional ownership reaching 34.41%. Calumet reported a substantial quarterly EPS loss of $3.64, missing estimates, though revenue rose 3.6% year-over-year.
Lombard Odier Asset Management USA Corp Has $2.14 Million Stock Holdings in Calumet, Inc. $CLMT
Lombard Odier Asset Management USA Corp significantly reduced its stake in Calumet, Inc. (NASDAQ:CLMT) by 40.5% in the first quarter, now holding shares worth $2.14 million. This comes amidst notable insider selling by Director Daniel J. Sajkowski and major shareholder Group Heritage, and a much wider-than-expected quarterly loss reported by Calumet. The stock currently holds an average "Hold" rating from analysts with an average target price of $36.75.
